238 related articles for article (PubMed ID: 16281956)
1. Hyporesponsiveness to erythropoietic therapy due to chronic inflammation.
Macdougall IC; Cooper AC
Eur J Clin Invest; 2005 Dec; 35 Suppl 3():32-5. PubMed ID: 16281956
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.
van der Putten K; Braam B; Jie KE; Gaillard CA
Nat Clin Pract Nephrol; 2008 Jan; 4(1):47-57. PubMed ID: 18094727
[TBL] [Abstract][Full Text] [Related]
3. Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation.
Icardi A; Paoletti E; De Nicola L; Mazzaferro S; Russo R; Cozzolino M
Nephrol Dial Transplant; 2013 Jul; 28(7):1672-9. PubMed ID: 23468534
[TBL] [Abstract][Full Text] [Related]
4. Could anti-inflammatory cytokine therapy improve poor treatment outcomes in dialysis patients?
Macdougall IC
Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V73-78. PubMed ID: 15284364
[TBL] [Abstract][Full Text] [Related]
5. Managing erythropoietin hyporesponsiveness.
Kwack C; Balakrishnan VS
Semin Dial; 2006; 19(2):146-51. PubMed ID: 16551293
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin: mechanisms of action and indications for treatment.
Vreugdenhil G; Frenken LA; Koene RA
Neth J Med; 1993 Jun; 42(5-6):187-202. PubMed ID: 8377877
[TBL] [Abstract][Full Text] [Related]
7. Hyporesponsiveness to erythropoiesis stimulating agents in chronic kidney disease: the many faces of inflammation.
Adamson JW
Adv Chronic Kidney Dis; 2009 Mar; 16(2):76-82. PubMed ID: 19233066
[TBL] [Abstract][Full Text] [Related]
8. Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis.
Morceau F; Dicato M; Diederich M
Mediators Inflamm; 2009; 2009():405016. PubMed ID: 20204172
[TBL] [Abstract][Full Text] [Related]
9. Possible role of cytokine-induced tryptophan degradation in anaemia of inflammation.
Weiss G; Schroecksnadel K; Mattle V; Winkler C; Konwalinka G; Fuchs D
Eur J Haematol; 2004 Feb; 72(2):130-4. PubMed ID: 14962250
[TBL] [Abstract][Full Text] [Related]
10. [Erythropoietin as a protective agent in myocardial ischemia].
Schwartzenberg S; Keren G; George J
Harefuah; 2006 May; 145(5):380-3, 396. PubMed ID: 16805223
[TBL] [Abstract][Full Text] [Related]
11. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure.
Opasich C; Cazzola M; Scelsi L; De Feo S; Bosimini E; Lagioia R; Febo O; Ferrari R; Fucili A; Moratti R; Tramarin R; Tavazzi L
Eur Heart J; 2005 Nov; 26(21):2232-7. PubMed ID: 15987710
[TBL] [Abstract][Full Text] [Related]
12. [Role of inflammation on renal anaemia].
Icardi A; Sacco P; Tarroni A; Cappelletti L; Cozzolino M
G Ital Nefrol; 2013; 30(6):. PubMed ID: 24402666
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma mediates suppression of erythropoiesis but not reduced red cell survival following CpG-ODN administration in vivo.
Thawani N; Tam M; Chang KH; Stevenson MM
Exp Hematol; 2006 Nov; 34(11):1451-61. PubMed ID: 17046564
[TBL] [Abstract][Full Text] [Related]
14. Evidence for downregulation of erythropoietin receptor in bone marrow erythroid cells of patients with chronic idiopathic neutropenia.
Pontikoglou C; Liapakis G; Pyrovolaki K; Papadakis M; Bux J; Eliopoulos GD; Papadaki HA
Exp Hematol; 2006 Oct; 34(10):1312-22. PubMed ID: 16982324
[TBL] [Abstract][Full Text] [Related]
15. Anemia and chronic heart failure implications and treatment options.
Anand IS
J Am Coll Cardiol; 2008 Aug; 52(7):501-11. PubMed ID: 18687241
[TBL] [Abstract][Full Text] [Related]
16. Implications of neocytolysis for optimal management of anaemia in chronic kidney disease.
Alfrey CP; Fishbane S
Nephron Clin Pract; 2007; 106(4):c149-56. PubMed ID: 17596723
[TBL] [Abstract][Full Text] [Related]
17. Cytokines and anaemia in human immunodeficiency virus infection.
Means RT
Cytokines Cell Mol Ther; 1997 Sep; 3(3):179-86. PubMed ID: 9426976
[TBL] [Abstract][Full Text] [Related]
18. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
El-Khatib M; Duncan HJ; Kant KS
Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines.
Macdougall IC; Cooper AC
Nephrol Dial Transplant; 2002; 17 Suppl 11():39-43. PubMed ID: 12386257
[TBL] [Abstract][Full Text] [Related]
20. Linking anemia to inflammation and cancer: the crucial role of TNFalpha.
Buck I; Morceau F; Grigorakaki C; Dicato M; Diederich M
Biochem Pharmacol; 2009 May; 77(10):1572-9. PubMed ID: 19174153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
